Celldex Therapeutics, Inc. shares tumbled yesterday on heavy ... The nimble investor can leverage our analysis and …
Celldex Therapeu has traded 7.0 million shares thus far today, vs. average volume of 3.6 million shares per day. The stock has outperformed the Dow (-53.5% to the Dow's -100.0%) and underperformed the S&P 500 (-53.5% to the S&P's …
Investors in Celldex Therapeutics, Inc. CLDX need to pay close attention to the stock based on moves in the options market lately. That is because the Apr 20 th 2018 $2.00 Put had some of the highest implied volatility of all equity …
Celldex is now “prioritizing” its pipeline and the company ... The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection. RDInvesting has not been compensated; directly or …
March has been a good month so far for Celldex Therapeutics (NASDAQ: CLDX) shareholders. The stock is up more than 20% this month, including a big jump last week that stemmed primarily from investor anticipation of the release of …